生物标志物 生物标志物
Danny De Sarno1, Jaspreet Bhangu2, Michael J Borrie2
1Western University, London, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究引入了一种精简的20分钟PET扫描协议,用于阿尔茨海默病 (AD) 诊断. 这种新方法有效地测量了粉样β (Aβ) 斑块积累和脑血流 (CBF),提高了诊断和预后能力.
科学领域:
- 核医学是一种核医学.
- 神经成像是一种神经成像.
- 阿尔茨海默氏症疾病的诊断方法
背景情况:
- 阳位子发射断层扫描 (PET) 对于阿尔茨海默病 (AD) 的诊断和监测至关重要.
- 目前用于粉样β (Aβ) 斑块 (BPND) 的PET方法需要超过100分钟的扫描.
- 大脑血流 (CBF) 评估是神经退行症的一个指标,通常需要单独的PET研究.
研究的目的:
- 从动态AβPET扫描来计算绝对脑血流 (CBF) 的新型处理工作流程.
- 通过缩短20分钟的动态扫描来估计Aβ的非可移位结合潜力 (BPND).
- 将CBF和BP测量集成到一个单一,高效的PET成像协议中.
主要方法:
- 利用了BioMind临床试验中的10名患者的数据,包括45分钟的动态18F-florbetabanPET扫描.
- 在CBF计算中采用了流量修改的2组织区模型 (F2TCM).
- 应用了洛根图形分析和交叉线性校准,用于从20分钟扫描中估计BPND.
主要成果:
- 从3分钟,20分钟和45分钟扫描中得出的CBF图表显示了可比的结果,在20分钟扫描中平均平方误差 (MSE) 很低 (18±11毫升/分钟/100克).
- 从20分钟扫描中校准的BPND显示出高精度,校准斜率为 (0.95±0.03) 和低MSE (0.0070±0.0013).
- 简化的协议成功地提供了CBF和BPND测量.
结论:
- 一个精简的20分钟的Aβ PET协议可以有效地测量BPND作为百叶状分数的替代品.
- 该协议还提供了补充CBF测量,提高了AD的诊断和预后效用.
- 这些发现支持了这种综合方法在更有效地评估AD方面的潜力.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516